Radiochemical and Biological Evaluation of 3p-<i>C</i>-NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics
Bifunctional chelators (BFCs) are a key element in the design of radiopharmaceuticals. By selecting a BFC that efficiently complexes diagnostic and therapeutic radionuclides, a theranostic pair possessing almost similar biodistribution and pharmacokinetic properties can be developed. We have previou...
Main Authors: | Erika Murce, Stephen Ahenkorah, Savanne Beekman, Maryana Handula, Debra Stuurman, Corrina de Ridder, Frederik Cleeren, Yann Seimbille |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/16/6/882 |
Similar Items
-
Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer
by: Erika Murce, et al.
Published: (2023-07-01) -
Preclinical Evaluation of a PSMA-Targeting Homodimer with an Optimized Linker for Imaging of Prostate Cancer
by: Erika Murce, et al.
Published: (2023-05-01) -
Bibliometric and scientometric analysis of PSMA-targeted radiotheranostics: knowledge mapping and global standing
by: Mohamed Sallam, et al.
Published: (2024-07-01) -
Development of a homotrimeric PSMA radioligand based on the NOTI chelating platform
by: Sebastian Martin, et al.
Published: (2024-12-01) -
eTFC-01: a dual-labeled chelate-bridged tracer for SSTR2-positive tumors
by: Dylan Chapeau, et al.
Published: (2024-05-01)